IL83275A - Compounds 1,2, 4-Oxadiazolyl Pipridine Transformed, their preparation and pharmaceutical preparations containing them - Google Patents

Compounds 1,2, 4-Oxadiazolyl Pipridine Transformed, their preparation and pharmaceutical preparations containing them

Info

Publication number
IL83275A
IL83275A IL8327587A IL8327587A IL83275A IL 83275 A IL83275 A IL 83275A IL 8327587 A IL8327587 A IL 8327587A IL 8327587 A IL8327587 A IL 8327587A IL 83275 A IL83275 A IL 83275A
Authority
IL
Israel
Prior art keywords
compound
methyl
oxalate
oxadiazol
tetrahydropyridinium
Prior art date
Application number
IL8327587A
Other languages
English (en)
Hebrew (he)
Other versions
IL83275A0 (en
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK426986A external-priority patent/DK426986D0/da
Priority claimed from DK597186A external-priority patent/DK597186D0/da
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL83275A0 publication Critical patent/IL83275A0/xx
Publication of IL83275A publication Critical patent/IL83275A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL8327587A 1986-09-08 1987-07-21 Compounds 1,2, 4-Oxadiazolyl Pipridine Transformed, their preparation and pharmaceutical preparations containing them IL83275A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK426986A DK426986D0 (da) 1986-09-08 1986-09-08 Piperidine forbindelser, deres fremstilling og anvendelse
DK597186A DK597186D0 (da) 1986-12-12 1986-12-12 Heterocykliske forbindelser, deres fremstilling og anvendelse

Publications (2)

Publication Number Publication Date
IL83275A0 IL83275A0 (en) 1987-12-31
IL83275A true IL83275A (en) 1994-02-27

Family

ID=26067417

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8327587A IL83275A (en) 1986-09-08 1987-07-21 Compounds 1,2, 4-Oxadiazolyl Pipridine Transformed, their preparation and pharmaceutical preparations containing them

Country Status (17)

Country Link
US (2) US4837241A (es)
EP (1) EP0259621B1 (es)
JP (1) JPH0662616B2 (es)
KR (1) KR950009366B1 (es)
AT (1) ATE82751T1 (es)
AU (1) AU603603B2 (es)
CA (1) CA1340937C (es)
DE (1) DE3782785T2 (es)
ES (1) ES2043624T3 (es)
FI (1) FI86424C (es)
GR (1) GR3007053T3 (es)
IE (1) IE62485B1 (es)
IL (1) IL83275A (es)
NO (1) NO169285C (es)
NZ (1) NZ221672A (es)
PH (1) PH23584A (es)
PT (1) PT85650B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
EP0322034A3 (en) * 1987-12-22 1991-01-02 Merck Sharp & Dohme Ltd. Methyl tetrahydropyridyl oxadiazoles
IL88846A0 (en) * 1988-01-08 1989-07-31 Merck Sharp & Dohme Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them
DK162892C (da) * 1988-07-04 1992-05-11 Novo Nordisk As 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
US5260311A (en) * 1989-02-22 1993-11-09 Novo Nordisk A/S Piperidine compounds and their use
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5264444A (en) * 1989-02-22 1993-11-23 Novo Nordisk A/S Piperidine compounds and use
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
EP0459568A3 (en) * 1990-05-31 1992-09-30 Merck Sharp & Dohme Ltd. Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use
MX9100517A (es) * 1990-08-06 1992-04-01 Smith Kline French Lab Compuestos
DK198490D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DE69129203T2 (de) * 1990-11-29 1998-12-03 Allergan Inc Verwendung von pyridine derivate zur behandlung der okulären hypertomie
US5175166A (en) * 1991-08-27 1992-12-29 The University Of Toledo Muscarinic agonists
EP0619814A1 (en) * 1991-12-31 1994-10-19 Fujisawa Pharmaceutical Co., Ltd. Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity
US5424301A (en) * 1993-02-01 1995-06-13 Warner-Lambert Company Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents
DE69418789T2 (de) * 1993-08-05 1999-12-02 Hoechst Marion Roussel Inc 2-(Piperidin-4-yl, Pyridin-4-yl und Tetrahydropyridin-4-yl)-benzofuran-7-carbamat Derivate, ihre Herstellung und Verwendung als Acetylcholinesterase Inhibitoren
US5753683A (en) * 1993-08-19 1998-05-19 Novo Nordisk A/S Antipsychotic method
US5998404A (en) 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
US5605908A (en) * 1994-10-24 1997-02-25 Eli Lilly And Company Heterocyclic compounds and their use
US5821370A (en) * 1994-10-24 1998-10-13 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5726193A (en) * 1994-10-31 1998-03-10 Eli Lilly And Company Method for treating anxiety
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety
US5574028A (en) * 1994-10-31 1996-11-12 Eli Lilly And Company Method for treating anxiety
JP2002500651A (ja) 1997-05-29 2002-01-08 ハー・ルンドベック・アクティーゼルスカブ 精神分裂病及び精神病の治療方法
WO1999032486A1 (en) * 1997-12-23 1999-07-01 Alcon Laboratories, Inc. Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
US7332508B2 (en) 2002-12-18 2008-02-19 Novo Nordisk A/S Substituted homopiperidine, piperidine or pyrrolidine derivatives
AU2005214378A1 (en) * 2004-02-18 2005-09-01 Astrazeneca Ab Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists
CA2556589A1 (en) * 2004-02-24 2005-09-01 Bioaxone Therapeutique Inc. 4-substituted piperidine derivatives
US8084473B2 (en) 2007-04-24 2011-12-27 Solvay Pharmaceuticals B.V. Heterocyclic compounds with affinity to muscarinic receptors
EP2150543A2 (en) * 2007-04-24 2010-02-10 Solvay Pharmaceuticals B.V. Heterocyclic compounds with affinity to muscarinic receptors
EP2296471A4 (en) 2008-05-15 2012-03-14 Univ Toledo MUSCARIC ACID AGONISTS AS COGNITIVE ENHANCERS
WO2012149524A1 (en) 2011-04-29 2012-11-01 The University Of Toledo Muscarinic agonists as enhancers of working memory and cognitive flexibility
US10149856B2 (en) 2015-01-26 2018-12-11 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US10857157B2 (en) 2015-01-26 2020-12-08 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US10106525B2 (en) 2015-01-26 2018-10-23 BioAxone BioSciences, Inc. Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US11198680B2 (en) 2016-12-21 2021-12-14 BioAxone BioSciences, Inc. Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US10537567B2 (en) 2017-07-11 2020-01-21 BioAxone BioSciences, Inc. Kinase inhibitors for treatment of disease
WO2020206410A1 (en) * 2019-04-04 2020-10-08 University Of Maryland, Baltimore Methods of using muscarinic antagonists in the treatment of depression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966748A (en) * 1975-05-08 1976-06-29 American Cyanamid Company Para-fluorophenyl-N-heterocyclic substituted butanes
US4518601A (en) * 1982-06-16 1985-05-21 Ciba Geigy Corporation 2-(3-Pyridyl)-1,3,4-oxadiazoles and use thereof in pest control
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders

Also Published As

Publication number Publication date
ES2043624T3 (es) 1994-01-01
FI86424B (fi) 1992-05-15
NZ221672A (en) 1990-09-26
DE3782785T2 (de) 1993-04-01
PT85650B (pt) 1990-05-31
US4933353A (en) 1990-06-12
DE3782785D1 (de) 1993-01-07
FI86424C (fi) 1992-08-25
NO873731L (no) 1988-03-09
JPH0662616B2 (ja) 1994-08-17
AU603603B2 (en) 1990-11-22
FI873809A (fi) 1988-03-09
ATE82751T1 (de) 1992-12-15
GR3007053T3 (es) 1993-07-30
EP0259621A2 (en) 1988-03-16
PH23584A (en) 1989-09-11
NO873731D0 (no) 1987-09-07
EP0259621A3 (en) 1988-10-12
IE872173L (en) 1989-03-08
NO169285B (no) 1992-02-24
US4837241A (en) 1989-06-06
NO169285C (no) 1992-06-03
IE62485B1 (en) 1995-02-08
EP0259621B1 (en) 1992-11-25
KR880003939A (ko) 1988-06-01
PT85650A (en) 1987-10-01
JPS6377877A (ja) 1988-04-08
KR950009366B1 (ko) 1995-08-21
AU7816587A (en) 1988-03-31
IL83275A0 (en) 1987-12-31
CA1340937C (en) 2000-03-28
FI873809A0 (fi) 1987-09-02

Similar Documents

Publication Publication Date Title
IL83275A (en) Compounds 1,2, 4-Oxadiazolyl Pipridine Transformed, their preparation and pharmaceutical preparations containing them
AU619770B2 (en) Azabicyclic or hydro-pyridine derivatives
US5043345A (en) Piperidine compounds and their preparation and use
AU662105B2 (en) Derivatives and azabicyclic oxadiazole or thiadiazole compounds
EP0687265B1 (en) Heterocyclic compounds and their preparation and use
JP3100158B2 (ja) 複素環化合物及びそれらの製造及び用途
US5330990A (en) Substituted urea compounds and their preparation and use
CZ290639B6 (cs) Azabicyklické sloučeniny a farmaceutický prostředek je obsahující
US5414009A (en) Azabicyclo substituted oxa- or thia-diazole compounds
WO1992003431A1 (en) Heterocyclic compounds and their preparation and use
JPH11508540A (ja) 新規の置換アザ環式またはアザ二環式化合物
EP0349956A1 (en) Azacyclic compounds and their preparation und use
DK172789B1 (da) Azacykliske og azabicykliske forbindelser, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende fo
DK155368B (da) Oxadiazolylpiperidinforbindelser, og farmaceutisk praeparat indeholdende saadanne forbindelser

Legal Events

Date Code Title Description
KB Patent renewed